Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults
Sutherland A., Naessens K., Plugge E., Head K., Burton MJ., Wee B.
ï¿½ 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of olanzapine when used as an anti-emetic in the prevention and treatment of nausea and vomiting related to cancer in adults.